Increased expression of growth hormone and prolactin receptors in hepatocellular carcinomas

被引:60
作者
García-Caballero, T
Mertani, HM
Lambert, A
Gallego, R
Fraga, M
Pintos, E
Forteza, J
Chevallier, M
Lobie, PE
Vonderhaar, BK
Beiras, A
Morel, G
机构
[1] Univ Santiago, Sch Med, Dept Morphol Sci, Santiago De Compostela 15705, Spain
[2] Univ Lyon 1, CNRS UMR 5578, F-69622 Villeurbanne, France
[3] Univ Hosp, Sch Med, Dept Pathol & Forens Sci, Santiago De Compostela, Spain
[4] Lab Marcel Merieux, Pathol Lab, Lyon, France
[5] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore
[6] NCI, Tumor Immunol & Biol Lab, Bethesda, MD 20892 USA
关键词
in situ hybridization; immunohistochemistry; mRNA expression; hepatocyte; liver;
D O I
10.1385/ENDO:12:3:265
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The liver is an essential target tissue for growth hormone (CH) and prolactin (PRL). The aim of this study was to determine the in situ expression of growth hormone receptor (GHR) and prolactin receptor (PRLR) in hepatocellular carcinomas and to compare the results with normal liver. For this purpose, in situ hybridization (ISH)and immunohistochemical techniques were performed and several tests were conducted to validate the results. By radioactive ISH, all the hepatocellular carcinomas studied showed labeling for GHR and PRLR mRNAs, Relative expression levels, determined by computer-assisted microdensity, were higher in hepatocellular carcinomas than in normal liver. Immunohistochemistry led us to confirm the constant expression of both receptor proteins in hepatocellular carcinomas and normal liver and to demonstrate their localization not only in the cytoplasm but also in the nucleus. These results confirm that the liver is a major CH and PRL target tissue and suggest that in hepatocellular carcinomas the proliferative effects of these hormones may be increased by a higher expression of their receptors.
引用
收藏
页码:265 / 271
页数:7
相关论文
共 47 条
  • [1] CHARACTERIZATION OF A MONOCLONAL-ANTIBODY AGAINST HUMAN PROLACTIN RECEPTORS
    BANERJEE, R
    GINSBURG, E
    VONDERHAAR, BK
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1993, 55 (05) : 712 - 721
  • [2] EVIDENCE FROM THE USE OF MONOCLONAL-ANTIBODY PROBES FOR STRUCTURAL HETEROGENEITY OF THE GROWTH-HORMONE RECEPTOR
    BARNARD, R
    BUNDESEN, PG
    RYLATT, DB
    WATERS, MJ
    [J]. BIOCHEMICAL JOURNAL, 1985, 231 (02) : 459 - 468
  • [4] CLONING AND EXPRESSION OF THE RAT PROLACTIN RECEPTOR, A MEMBER OF THE GROWTH-HORMONE PROLACTIN RECEPTOR GENE FAMILY
    BOUTIN, JM
    JOLICOEUR, C
    OKAMURA, H
    GAGNON, J
    EDERY, M
    SHIROTA, M
    BANVILLE, D
    DUSANTERFOURT, I
    DJIANE, J
    KELLY, PA
    [J]. CELL, 1988, 53 (01) : 69 - 77
  • [5] IDENTIFICATION OF A CDNA-ENCODING A LONG FORM OF PROLACTIN RECEPTOR IN HUMAN HEPATOMA AND BREAST-CANCER CELLS
    BOUTIN, JM
    EDERY, M
    SHIROTA, M
    JOLICOEUR, C
    LESUEUR, L
    ALI, S
    GOULD, D
    DJIANE, J
    KELLY, PA
    [J]. MOLECULAR ENDOCRINOLOGY, 1989, 3 (09) : 1455 - 1461
  • [6] IDENTIFICATION OF PROLACTIN RECEPTORS IN HEPATIC NUCLEI
    BUCKLEY, AR
    MONTGOMERY, DW
    HENDRIX, MJC
    ZUKOSKI, CF
    PUTNAM, CW
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 296 (01) : 198 - 206
  • [7] RAPID ACTIVATION OF PROTEIN KINASE-C IN ISOLATED RAT-LIVER NUCLEI BY PROLACTIN, A KNOWN HEPATIC MITOGEN
    BUCKLEY, AR
    CROWE, PD
    RUSSELL, DH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) : 8649 - 8653
  • [8] Molecular mechanism of growth hormone action
    CarterSu, C
    Schwartz, J
    Smit, LS
    [J]. ANNUAL REVIEW OF PHYSIOLOGY, 1996, 58 : 187 - 207
  • [9] ABSENCE OF GROWTH-HORMONE RECEPTOR IN HEPATOCELLULAR-CARCINOMA AND CIRRHOTIC LIVER
    CHANG, TC
    LIN, JJ
    YU, SC
    CHANG, TJ
    [J]. HEPATOLOGY, 1990, 11 (01) : 123 - 126
  • [10] THE HEMATOPOIETIN RECEPTOR SUPERFAMILY
    COSMAN, D
    [J]. CYTOKINE, 1993, 5 (02) : 95 - 106